Aditya Raj
Vice President @Scrmp - Society Of Clinical Research And Medical Professionals
Signup · Get unlimited contacts
WORK HISTORY
Vice President @Scrmp - Society Of Clinical Research And Medical Professionals
IN
EDUCATION
Regional Secondary School (CBSC)
Matriculation , Basic Skills and Developmental/Remedial Education
ISF COLLEGE OF PHARMACY
Doctor of Pharmacy - PharmD, Pharmacy
M.T Vidyapeeth (CBSE)
Intermediate , PCB
I. K. Gujral Punjab Technical University (IKGPTU)
Doctor of Pharmacy - PharmD, Clinical, Hospital, and Managed Care Pharmacy
ABOUT ADITYA RAJ
I am a research scholar with a growing academic foundation in clinical research, pharmacovigilance, and scientific writing. My work reflects a consistent interest in evidence-based practice, drug safety, and the translation of research findings into meaningful clinical insights. Through my roles across professional societies and student-led organizations, I have developed experience in research coordination, editorial review, and scientific communication.I currently serve as the Vice President of the SCRMP West Bengal Chapter and previously led the Research and Editorial division, where I oversaw the curation of scientific content and supported initiatives that promote academic quality within the student community. My involvement as an ADR Reporting Coordinator has strengthened my understanding of patient safety, adverse event reporting, and regulatory expectations in pharmacovigilance. Alongside these responsibilities, I contribute as a Student Co-Editor, which has further refined my editorial skills and engagement with academic writing.My membership in professional organizations including ASCO, ASCPT, AAN, AACR, ESMO, BSAC, ISPOR, and IFCAI has broadened my perspective on clinical oncology, pharmacology, antimicrobial stewardship, and health outcomes research. These affiliations allow me to participate in scientific dialogues and stay updated with current developments in therapeutics and clinical practice.I have authored publications on phosphodiesterase-4 inhibitors and MET inhibition in non small cell lung cancer, reflecting my interest in therapeutic mechanisms and their clinical relevance. I aim to continue building expertise in clinical research, medical writing, and evidence evaluation while contributing to academic and professional communities committed to advancing healthcare.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.